Gelatin nanoparticles could deliver drugs to the brain

December 24, 2014 by Liz Ahlberg, University of Illinois at Urbana-Champaign
Illinois professor Kyekyoon “Kevin” Kim, graduate student Elizabeth Joachim and research scientist Hyungsoo Choi developed tiny gelatin nanoparticles that can carry medication to the brain, which could lead to longer treatment windows for stroke patients. Credit: L. Brian Stauffer

Stroke victims could have more time to seek treatment that could reduce harmful effects on the brain, thanks to tiny blobs of gelatin that could deliver the medication to the brain noninvasively.

University of Illinois researchers and colleagues in South Korea, led by U. of I. electrical and computer engineering senior research scientist Hyungsoo Choi and professor Kyekyoon "Kevin" Kim, published details about the gelatin nanoparticles in the journal Drug Delivery and Translational Research.

The researchers found that gelatin nanoparticles could be laced with medications for delivery to the brain, and that they could extend the treatment window for when a could be effective. Gelatin is biocompatible, biodegradable, and classified as "Generally Recognized as Safe" by the Food and Drug Administration. Once administered, the gelatin nanoparticles target damaged brain tissue thanks to an abundance of gelatin-munching enzymes produced in injured regions.

The tiny gelatin particles have a huge benefit: They can be administered nasally, a noninvasive and direct route to the brain. This allows the drug to bypass the , a biological fence that prevents the vast majority of drugs from entering the brain through the bloodstream.

"Overcoming the difficulty of delivering therapeutic agents to specific regions of the brain presents a major challenge to treatment of most neurological disorders," said Choi. "However, if drug substances can be transferred along the olfactory nerve cells, they can bypass the blood-brain barrier and enter the brain directly."

To test gelatin nanoparticles as a drug-delivery system, the researchers used the drug osteopontin (OPN), which in rats can help to reduce inflammation and prevent if administered immediately after a stroke.

"It is crucial to treat ischemic strokes within three hours to improve the chances of recovery. However, a significant number of don't get to the hospital in time for the treatment," Kim said.

By lacing gelatin nanoparticles with OPN, the researchers found that they could extend the treatment window in rats, so much so that treating a rat with nanoparticles six hours after a stroke showed the same efficacy rate as giving them OPN alone after one hour – 70 percent recovery of dead volume in the brain.

The researchers hope the nanoparticles, administered through the nasal cavity, can help deliver other drugs to more effectively treat a variety of brain injuries and neurological diseases.

"Gelatin are a delivery vehicle that could be used to deliver many therapeutics to the brain," Choi said. "They will be most effective in delivering drugs that cannot cross the blood- barrier. In addition, they can be used for drugs of high toxicity or a short half-life."

Explore further: Blocking blood-brain barrier proteins may improve ALS drugs' effectiveness

More information: "Gelatin nanoparticles enhance the neuroprotective effects of intranasally administered osteopontin in rat ischemic stroke model." Drug Delivery and Translational Research December 2014, Volume 4, Issue 5-6, pp 395-399 link.springer.com/article/10.1 … %2Fs13346-014-0208-9

Related Stories

New method for making human-based gelatin

July 13, 2011

Scientists are reporting development of a new approach for producing large quantities of human-derived gelatin that could become a substitute for some of the 300,000 tons of animal-based gelatin produced annually for gelatin-type ...

Recommended for you

Bright colors produced by laser heating

January 15, 2019

Most of the colors on today's paper and fabric are made using dyes or pigments. But colors can also be produced by modifying a material's surface at the nanoscale, causing the surface to reflect or scatter different frequencies ...

Pore size influences nature of complex nanostructures

January 15, 2019

Building at the nanoscale is not like building a house. Scientists often start with two-dimensional molecular layers and combine them to form complex three-dimensional architectures. And instead of nails and screws, these ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

BSD
1 / 5 (1) Dec 24, 2014
Not for Jews and Muslims it won't.
dan42day
not rated yet Dec 25, 2014
I thought I'd read that Bill Cosby had done research in this area some years ago.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.